BWL
CTKB icon

Bogart Wealth LLC’s Cytek Biosciences CTKB Stock Holding History

Bogart Wealth LLC’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-24
Closed -$205 – 1077
2023
Q2 		$205 Hold
24
– – ﹤0.01% 1020
2023
Q1 		$221 Buy
+24
New +$258 ﹤0.01% 1076

Other funds holding CTKB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bogart Wealth LLC's CTKB Position: Q3 2023 in Review

Bogart Wealth LLC sold out of Cytek Biosciences (CTKB) in Q3 2023, closing a stake of 24 shares — an estimated $205 sold.

Bogart Wealth LLC first reported a position in CTKB in Q1 2023 and held it in 2 quarters. The position peaked at $221 in Q1 2023. 106 funds tracked by Wall St. Rank hold CTKB as of Q3 2023.

  • Bogart Wealth LLC reported no remaining Cytek Biosciences position as of Q3 2023 after selling out during the quarter.
  • Bogart Wealth LLC sold 24 Cytek Biosciences shares in Q3 2023, an estimated $205.
  • Bogart Wealth LLC first reported a position in Cytek Biosciences in Q1 2023 and held it in 2 quarters.
  • Bogart Wealth LLC's Cytek Biosciences position peaked at $221 in Q1 2023.
  • 106 funds tracked by Wall St. Rank held Cytek Biosciences as of Q3 2023.

Based on Bogart Wealth LLC's 13F filing for Q3 2023, filed 30 Oct 2023.